Bioimplants Market by Type (Cardiovascular Bioimplants, Dental Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants, and Ophthalmology Bioimplants), Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials) - Global Opportunity Analysis and Industry Forecast, 2017-2023
- ALL2599957
- 225 Pages
- May 2018
- Healthcare
Bioimplant are medical devices or tissues that are surgically transplanted inside the body. These implants are used to replace or support any damaged body organs to enhance function of any body organ or to detect errors in normal body functioning. These can be either placed permanently or temporarily in human body and can be removed when they are no longer needed. Some of the implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other materials.
The global bioimplant market was evaluated at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period. The growth in the bioimplant market is primarily attributed to the rise in prevalence of chronic diseases coupled with the rapidly aging population. Moreover, increased awareness and technological advancements in bioimplant further support the growth of the market. However, high implantation cost and lack of expertise are some of the factors that restrain the growth of the bioimplant market.
The global bioimplant market is segmented based on product type, material, and region. Based on product type, the market is categorized into cardiovascular implant, dental implant, orthopedic implant, spinal implant, ophthalmic implant, and others. By material type, it is divided into metallic biomaterial, ceramic biomaterial, polymer biomaterial, and natural biomaterials. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging trends and dynamics in the global bioimplants market to identify the prevailing opportunities.
- It presents a competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- and country-wise analyses are provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Type
- Cardiovascular bioimplant
- Stent
- Coronary stent
- Drug-eluting stent (DES)
- Bare-metal coronary stent
- Bioabsorbable stent
- Peripheral stent
- Iliac
- Femoral-popliteal
- Renal
- Carotid
- Stent-related bioimplant
- Synthetic graft
- Vena Cava filter
- Pacing device
- Cardiac resynchronization therapy device (CRTs)
- Implantable cardioverter defibrillator (ICDs)
- Implantable cardiac pacemaker (ICPs)
- Structural Cardiac Implant
- Mechanical heart valve
- Implantable ventricular-assist device
- Stent
- Dental bioimplant
- Plate form dental implant
- Root form dental implant
- Orthopedic bioimplant
- Reconstructive joint replacement
- Knee replacement implant
- Hip replacement implant
- Extremities
- Orthobiologics
- Trauma & craniomaxillofacial
- Spinal bioimplant
- Spinal fusion implant
- Spinal bone stimulator
- Vertebral compression fracture (VCF) device
- Motion preservation devices/non-fusion device
- Spine biologics
- Ophthalmology bioimplant
- Glaucoma implant
- Intraocular implant
- Others
By material
- Metallic biomaterial
- Ceramic biomaterial
- Polymers biomaterial
- Natural biomaterial
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
The key players profiled in this report are as follows:
- Abbott Laboratories (St. Jude Medical, Inc.)
- Boston Scientific Corporation
- Dentsply Sirona Inc.
- Johnson & Johnson (Ethicon, Inc.)
- Medtronic plc
- Smith & Nephew plc
- Stryker Corporation
- Victrex Plc. (Invibio Ltd.)
- Wright Medical Group N.V.
- Zimmer Biomet Holdings Inc.
The other players in the value chain include (*These players have not been profiled in the report, but can be included on request.):
- GC Aesthetics plc
- Allergan Inc.
- Sientra Inc.
- Danaher Corporation
- 3M Company
- Polytech Health & Aesthetics GmbH
- B. Braun Melsungen AG
- Elixir Medical Corporation
- Microport Scientific Corporation
- STENTYS S.A.
- Terumo Corporation
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2016
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growth in elderly population and rise in prevalence of chronic diseases
3.4.1.2. Technological advancements in the field of bioimplant
3.4.1.3. Global rise in acceptance of bioimplant
3.4.1.4. Better insurance and reimbursement
3.4.1.5. Increase in government focus on funding R&D initiatives
3.4.2. Restraints
3.4.2.1. High cost of treatment associated with bioimplant
3.4.2.2. Stringent approval process
3.4.3. Opportunities
3.4.3.1. Huge market opportunities in the APAC region and developing countries
3.4.3.2. Increase in development of minimally invasive and non-surgical procedures
3.4.3.3. Rise in awareness amongst patients and increasing preference for a better quality of life
3.4.4. Impact analysis
CHAPTER 4: BIOIMPLANT MARKET BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Cardiovascular implant
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Stent
4.2.3.1. Market size and forecast
4.2.3.2. Coronary stent
4.2.3.2.1. Market size and forecast
4.2.3.2.2. Drug-eluting stent
4.2.3.2.2.1. Market size and forecast
4.2.3.2.3. Bare-metal coronary stent
4.2.3.2.3.1. Market size and forecast
4.2.3.2.4. Bioabsorbable stent
4.2.3.2.4.1. Market size and forecast
4.2.3.3. Peripheral stent
4.2.3.3.1. Market size and forecast
4.2.3.3.2. Iliac stent
4.2.3.3.2.1. Market size and forecast
4.2.3.3.3. Femoral-popliteal stent
4.2.3.3.3.1. Market size and forecast
4.2.3.3.4. Renal stent
4.2.3.3.4.1. Market size and forecast
4.2.3.3.5. Carotid stent
4.2.3.3.5.1. Market size and forecast
4.2.3.4. Stent-related implant
4.2.3.4.1. Market size and forecast
4.2.3.4.2. Synthetic graft
4.2.3.4.2.1. Market size and forecast
4.2.3.4.3. Vena cava filter
4.2.3.4.3.1. Market size and forecast
4.2.4. Pacing device
4.2.4.1. Market size and forecast
4.2.4.2. Cardiac resynchronisation therapy (CRT)
4.2.4.2.1. Market size and forecast
4.2.4.3. Implantable cardioverter defibrillators (ICDs)
4.2.4.3.1. Market size and forecast
4.2.4.4. Implantable cardiac pacemaker (ICP)
4.2.4.4.1. Market size and forecast
4.2.5. Structural cardiac implant
4.2.5.1. Market size and forecast
4.2.5.2. Mechanical heart valve
4.2.5.2.1. Market size and forecast
4.2.5.3. Implantable ventricular-assist device (VAD)
4.2.5.3.1. Market size and forecast
4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country
4.3. Dental and prosthetic implant
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Plate form dental implants
4.3.2.1.1. Market size and forecast
4.3.2.2. Root form dental implants
4.3.2.2.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. Orthopedic implant
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Reconstructive joint replacements
4.4.2.1.1. Market size and forecast
4.4.2.1.2. Knee replacement implants
4.4.2.1.2.1. Market size and forecast
4.4.2.1.3. Hip replacement implants
4.4.2.1.3.1. Market size and forecast
4.4.2.1.4. Extremities
4.4.2.1.4.1. Market size and forecast
4.4.2.2. Orthobiologics
4.4.2.2.1. Market size and forecast
4.4.2.3. Trauma & craniomaxillofacial
4.4.2.3.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country
4.5. Ophthalmic implants
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by type
4.5.2.1. Intraocular lens
4.5.2.1.1. Market size and forecast
4.5.2.2. Glaucoma implant
4.5.2.2.1. Market size and forecast
4.5.3. Market size and forecast, by region
4.5.4. Market analysis, by country
4.6. Spinal implants
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by type
4.6.2.1. Spinal fusion devices
4.6.2.1.1. Market size and forecast
4.6.2.2. Motion preservation device
4.6.2.2.1. Market size and forecast
4.6.2.3. Vertebral compression fracture (VCF) devices
4.6.2.3.1. Market size and forecast
4.6.2.4. Spinal bone stimulators
4.6.2.4.1. Market size and forecast
4.6.2.5. Spine biologics
4.6.2.5.1. Market size and forecast
4.6.3. Market size and forecast, by region
4.6.4. Market analysis, by country
4.7. Other implants
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
CHAPTER 5: BIOIMPLANT MARKET, BY MATERIAL
5.1. Overview
5.1.1. Market size and forecast
5.2. Metallic Biomaterials
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Ceramic Biomaterial
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Polymer Biomaterial
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Natural Biomaterials
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
CHAPTER 6: BIOIMPLANT MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S. bioimplant market size and forecast
6.2.2.1.1. U.S. bioimplant market size and forecast, by product
6.2.2.1.2. U.S. bioimplant market size and forecast, by material
6.2.2.2. Canada bioimplant market size and forecast
6.2.2.2.1. Canada bioimplant market size and forecast, by product
6.2.2.2.2. Canada bioimplant market size and forecast, by material
6.2.2.3. Mexico bioimplant market size and forecast
6.2.2.3.1. Mexico bioimplant market size and forecast, by product
6.2.2.3.2. Mexico bioimplant market size and forecast, by material
6.2.3. North America market size and forecast, by product
6.2.4. North America market size and forecast, by material
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe market size and forecast, by country
6.3.2.1. Germany bioimplant market size and forecast
6.3.2.1.1. Germany bioimplant market size and forecast, by product
6.3.2.1.2. Germany bioimplant market size and forecast, by material
6.3.2.2. France bioimplant market size and forecast
6.3.2.2.1. France bioimplant market size and forecast, by product
6.3.2.2.2. France bioimplant market size and forecast, by material
6.3.2.3. UK bioimplant market size and forecast
6.3.2.3.1. UK bioimplant market size and forecast, by product
6.3.2.3.2. UK bioimplant market size and forecast, by material
6.3.2.4. Italy bioimplant market size and forecast
6.3.2.4.1. Italy bioimplant market size and forecast, by product
6.3.2.4.2. Italy bioimplant market size and forecast, by material
6.3.2.5. Spain bioimplant market size and forecast
6.3.2.5.1. Spain bioimplant market size and forecast, by product
6.3.2.5.2. Spain bioimplant market size and forecast, by material
6.3.2.6. Rest of Europe bioimplant market size and forecast
6.3.2.6.1. Rest of Europe bioimplant market size and forecast, by product
6.3.2.6.2. Rest of Europe bioimplant market size and forecast, by material
6.3.3. Europe market size and forecast, by product
6.3.4. Europe market size and forecast, by material
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan bioimplant market size and forecast
6.4.2.1.1. Japan bioimplant market size and forecast, by product
6.4.2.1.2. Japan bioimplant market size and forecast, by material
6.4.2.2. China bioimplant market size and forecast
6.4.2.2.1. China bioimplant market size and forecast, by product
6.4.2.2.2. China bioimplant market size and forecast, by material
6.4.2.3. India bioimplant market size and forecast
6.4.2.3.1. India bioimplant market size and forecast, by product
6.4.2.3.2. India bioimplant market size and forecast, by material
6.4.2.4. Australia bioimplant market size and forecast
6.4.2.4.1. Australia bioimplant market size and forecast, by product
6.4.2.4.2. Australia bioimplant market size and forecast, by material
6.4.2.5. Rest of Asia-Pacific bioimplant market size and forecast
6.4.2.5.1. Rest of Asia-Pacific bioimplant market size and forecast, by product
6.4.2.5.2. Rest of Asia-Pacific bioimplant market size and forecast, by material
6.4.3. Asia-Pacific market size and forecast, by product
6.4.4. Asia-Pacific market size and forecast, by material
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Brazil bioimplant market size and forecast
6.5.2.1.1. Brazil bioimplant market size and forecast, by product
6.5.2.1.2. Brazil bioimplant market size and forecast, by material
6.5.2.2. South Africa bioimplant market size and forecast
6.5.2.2.1. South Africa bioimplant market size and forecast, by product
6.5.2.2.2. South Africa bioimplant market size and forecast, by material
6.5.2.3. Saudi Arabia bioimplant market size and forecast
6.5.2.3.1. Saudi Arabia bioimplant market size and forecast, by product
6.5.2.3.2. Saudi Arabia bioimplant market size and forecast, by material
6.5.2.4. Rest of LAMEA bioimplant market size and forecast
6.5.2.4.1. Rest of LAMEA bioimplant market size and forecast, by product
6.5.2.4.2. Rest of LAMEA bioimplant market size and forecast, by material
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by material
CHAPTER 7: COMPANY PROFILES
7.1. Abbott Laboratories (St. Jude Medical, Inc.)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Boston Scientific Corporation
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Dentsply Sirona Inc.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Johnson & Johnson (Ethicon, Inc.)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Medtronic plc
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Smith & Nephew plc
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Stryker Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Victrex Plc. (Invibio Ltd.)
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Wright Medical Group N.V.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. Zimmer Biomet Holdings Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. BIOIMPLANT MARKET REVENUE, BY TYPE, 2016-2023 ($MILLION)
TABLE 02. CARDIOVASCULAR IMPLANT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 03. STENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 04. CORONARY STENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 05. PERIPHERAL STENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 06. STENT RELATED IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 07. PACING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 08. STRUCTURAL CARDIAC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 09. CARDIOVASCULAR BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. DENTAL BIOIMPLANT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 11. DENTAL BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 13. RECONSTRUCTIVE JOINT REPLACEMENTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 14. ORTHOPEDIC BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. OPHTHALMIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. OPHTHALMOLOGY BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. SPINAL BIOIMPLANT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. SPINAL BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. OTHER BIOIMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL BIOIMPLANT MARKET, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 21. METALLIC BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. CERAMIC BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. POLYMERS BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. NATURAL BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. BIOIMPLANT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. U.S. BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. U.S. BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 29. CANADA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 30. CANADA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 31. MEXICO BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 32. MEXICO BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 35. EUROPE BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. GERMANY BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 37. GERMANY BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 38. FRANCE BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 39. FRANCE BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 40. UK BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 41. UK BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 42. ITALY BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. ITALY BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 44. SPAIN BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 45. SPAIN BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 46. REST OF EUROPE BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 47. REST OF EUROPE BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 48. EUROPE BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 49. EUROPE BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 50. ASIA-PACIFIC BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 51. JAPAN BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 52. JAPAN BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 53. CHINA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 54. CHINA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 55. INDIA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 56. INDIA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 57. AUSTRALIA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 58. AUSTRALIA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 59. REST OF ASIA-PACIFIC BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 60. REST OF ASIA-PACIFIC BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 61. ASIA-PACIFIC BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 62. ASIA-PACIFIC BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 63. LAMEA BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 64. BRAZIL BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 65. BRAZIL BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 66. SOUTH AFRICA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 67. SOUTH AFRICA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 68. SAUDI ARABIA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 69. SAUDI ARABIA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 70. REST OF LAMEA BIOIMPLANT MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 71. REST OF LAMEA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 72. LAMEA BIOIMPLANT MARKET REVENUE, BY TYPE, 2016-2023 ($MILLION)
TABLE 73. LAMEA BIOIMPLANT MARKET REVENUE, BY MATERIAL, 2016-2023 ($MILLION)
TABLE 74. ABBOTT: COMPANY SNAPSHOT
TABLE 75. ABBOTT: OPERATING SEGMENTS
TABLE 76. ABBOTT: PRODUCT PORTFOLIO
TABLE 77. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 78. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 79. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 80. DENTSPLY SIRONA: COMPANY SNAPSHOT
TABLE 81. DENTSPLY SIRONA: OPERATING SEGMENTS
TABLE 82. DENTSPLY SIRONA: PRODUCT PORTFOLIO
TABLE 83. J&J: COMPANY SNAPSHOT
TABLE 84. J&J: OPERATING SEGMENTS
TABLE 85. J&J: PRODUCT PORTFOLIO
TABLE 86. MEDTRONIC: COMPANY SNAPSHOT
TABLE 87. MEDTRONIC: OPERATING SEGMENTS
TABLE 88. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 89. SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 90. SMITH & NEPHEW: PRODUCT SEGMENTS
TABLE 91. SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 92. STRYKER: COMPANY SNAPSHOT
TABLE 93. STRYKER: OPERATING SEGMENTS
TABLE 94. STRYKER: PRODUCT PORTFOLIO
TABLE 95. VICTREX: COMPANY SNAPSHOT
TABLE 96. VICTREX: PRODUCT SEGMENTS
TABLE 97. VICTREX: PRODUCT PORTFOLIO
TABLE 98. WRIGHT: COMPANY SNAPSHOT
TABLE 99. WRIGHT: PRODUCT SEGMENTS
TABLE 100. WRIGHT: PRODUCT PORTFOLIO
TABLE 101. ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 102. ZIMMER BIOMET: PRODUCT SEGMENTS
TABLE 103. ZIMMER BIOMET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. BIOIMPLANT MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. IMPACT ANALYSES, 2016
FIGURE 07. DRUG-ELUTING STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 08. BARE METAL STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 09. BIOABSORBABLE VASCULAR STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 10. ILIAC STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 11. FEMORAL-POPLITEAL STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 12. RENAL STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 13. CAROTID STENT MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 14. SYNTHETIC GRAFTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 15. VENA CAVA FILTERS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 16. CARDIAC RESYNCHRONIZATION THERAPY (CRT) MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 17. IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (ICD) MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 18. IMPLANTABLE CARDIAC PACEMAKERS (ICPS) MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 19. MECHANICAL VALVES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 20. VENTRICULAR-ASSIST DEVICES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF CARDIOVASCULAR BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 22. PLATE FORM DENTAL IMPLANTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 23. ROOT FORM DENTAL IMPLANTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF DENTAL BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 25. KNEE REPLACEMENT IMPLANTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 26. HIP REPLACEMENT IMPLANTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 27. EXTREMITIES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 28. ORTHOBIOLOGICS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 29. TRAUMA & CRANIOMAXILLOFACIAL MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 30. COMPARATIVE ANALYSIS OF ORTHOPEDIC BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 31. INTRAOCULAR LENS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 32. GLAUCOMA IMPLANTS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 33. COMPARATIVE ANALYSIS OF OPHTHALMOLOGY BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 34. SPINAL FUSION DEVICES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 35. MOTION PRESERVATION DEVICES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 36. VERTEBRAL COMPRESSION FRACTURE DEVICES MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 37. SPINAL BONE STIMULATORS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 38. SPINE BIOLOGICS MARKET REVENUE, 2016-2023 ($MILLION)
FIGURE 39. COMPARATIVE ANALYSIS OF SPINAL IMPLANTS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 40. COMPARATIVE ANALYSIS OF OTHER BIOIMPLANT MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 41. COMPARATIVE ANALYSIS OF METALLIC BIOMATERIALS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 42. COMPARATIVE ANALYSIS OF CERAMIC BIOMATERIALS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 43. COMPARATIVE ANALYSIS OF POLYMERS BIOMATERIALS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 44. COMPARATIVE ANALYSIS OF NATURAL BIOMATERIALS MARKET REVENUE, BY COUNTRY, 2016 & 2023 (%)
FIGURE 45. ABBOTT: NET SALES, 2015-2017 ($MILLION)
FIGURE 46. ABBOTT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 47. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 48. BOSTON SCIENTIFIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 49. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 51. DENTSPLY SIRONA: NET SALES, 2015-2017 ($MILLION)
FIGURE 52. DENTSPLY SIRONA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 53. DENTSPLY SIRONA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 54. J&J: NET SALES, 2017-2016 ($MILLION)
FIGURE 55. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 56. J&J: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 57. MEDTRONIC: NET SALES, 2015-2017 ($MILLION)
FIGURE 58. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 60. SMITH & NEPHEW: NET SALES, 2015-2017 ($MILLION)
FIGURE 61. SMITH & NEPHEW: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 62. SMITH & NEPHEW: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 63. STRYKER: NET SALES, 2015-2017 ($MILLION)
FIGURE 64. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 65. STRYKER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 66. VICTREX: NET SALES, 2015-2017 ($MILLION)
FIGURE 67. VICTREX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 68. VICTREX: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 69. WRIGHT: NET SALES, 2015-2017 ($MILLION)
FIGURE 70. WRIGHT: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 71. WRIGHT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 72. ZIMMER BIOMET: NET SALES, 2015-2017 ($MILLION)
FIGURE 73. ZIMMER BIOMET: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 74. ZIMMER BIOMET: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
